Metabolic Disease Enzyme Replacement, Gaucher's Disease

"Metabolic Disease Enzyme Replacement, Gaucher's Disease" is an administrative and formulary classification rather than a formal physiological drug class It encompasses exogenous, recombinant glucocerebrosidase enzymes—such as imiglucerase, velaglucerase alfa, and taliglucerase alfa—used as enzyme replacement therapy

"Metabolic Disease Enzyme Replacement, Gaucher's Disease" is an administrative and formulary classification rather than a formal physiological drug class

It encompasses exogenous, recombinant glucocerebrosidase enzymes—such as imiglucerase, velaglucerase alfa, and taliglucerase alfa—used as enzyme replacement therapy The class is specifically indicated for the management of non-neurological manifestations of Gaucher disease, primarily Type 1 and non-central nervous system manifestations of Type 3, alleviating hepatosplenomegaly, anemia, thrombocytopenia, and skeletal disease

These agents function by replacing deficient endogenous beta-glucocerebrosidase, thereby catalyzing the hydrolysis of accumulated glucocerebroside into glucose and ceramide within macrophage lysosomes The class is specifically indicated for the management of non-neurological manifestations of Gaucher disease, primarily Type 1 and non-central nervous system manifestations of Type 3, alleviating hepatosplenomegaly, anemia, thrombocytopenia, and skeletal disease

The class is specifically indicated for the management of non-neurological manifestations of Gaucher disease, primarily Type 1 and non-central nervous system manifestations of Type 3, alleviating hepatosplenomegaly, anemia, thrombocytopenia, and skeletal disease